About Steril-Gene
Steril-Gene is a company based in Chennai (India) founded in 2010. It operates as a B2B. The company has 957 employees as of March 31, 2023. Steril-Gene offers products and services including Contract Manufacturing, Technology Transfer, Injectables, and Tablets and Capsules. Steril-Gene operates in a competitive market with competitors including Unither, Akums, Jubilant Life Sciences, Recipharm and CoreRx, among others.
- Headquarter Chennai, India
- Employees 957 as on 31 Mar, 2023
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Steril-Gene Life Sciences Private Limited
- Date of Incorporation 28 Feb, 2007
- Jurisdiction Chennai, Tamil Nadu, India
-
Annual Revenue
$27.16 M (USD)21.76as on Mar 31, 2023
-
Net Profit
-$2.68 M (USD)-421.99as on Mar 31, 2023
-
EBITDA
$1.81 M (USD)-66.84as on Mar 31, 2023
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
957
as on Mar 31, 2023
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Steril-Gene
Steril-Gene offers a comprehensive portfolio of products and services, including Contract Manufacturing, Technology Transfer, Injectables, and Tablets and Capsules.
Provides production of pharmaceutical injectables and tablets for clients.
Facilitates transfer of pharmaceutical production processes worldwide.
Manufactures sterile injectables for medical and therapeutic use.
Produces oral solid dosage forms for various health applications.
People of Steril-Gene
Unlock access to complete
Funding Insights of Steril-Gene
Detailed funding history for Steril-Gene
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Steril-Gene
Investment portfolio details for Steril-Gene
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Steril-Gene
Detailed financials for Steril-Gene
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Steril-Gene Comparisons
Peer comparison for Steril-Gene
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Steril-Gene
Steril-Gene operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Unither, Akums, Jubilant Life Sciences, Recipharm and CoreRx, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Contract development and manufacturing organization for proprietary and generic drugs
|
|
| Locked | Locked | Locked |
CDMO focusing on spectrum of dosage forms and therapeutic segments
|
|
| Locked | Locked | Locked |
Company offering a suite of R&D and manufacturing services for small molecules and generics
|
|
| Locked | Locked | Locked |
Pharmaceutical development and manufacturing services are offered contractually.
|
|
| Locked | Locked | Locked |
CDMO with a focus on early phase drug product development
|
|
| Locked | Locked | Locked |
Cephalosporin APIs and generic formulations are manufactured.
|
Detailed competitors of Steril-Gene
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Steril-Gene
Complete news archive for Steril-Gene
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Steril-Gene
Steril-Gene was founded in 2010.
Steril-Gene is headquartered in Chennai, India. It is registered at Chennai, Tamil Nadu, India.
As of Mar 31, 2023, the latest employee count at Steril-Gene is 957.
Annual revenue of Steril-Gene is $27.16M as on Mar 31, 2023.
Steril-Gene Life Sciences is a pharmaceutical company specializing in contract development and manufacturing of products like injectables, tablets, and capsules. It operates from facilities in Puducherry and Chennai, India, adhering to US FDA standards. The company serves global pharmaceutical firms by providing end-to-end services, including technology transfers and regulatory support, to ensure seamless production and distribution of quality medicines.
Steril-Gene's top competitors include Jubilant Life Sciences, Akums and Nectar Lifesciences.
Steril-Gene offers Contract Manufacturing, Technology Transfer, Injectables, and Tablets and Capsules.